Cape Investment Advisory »

Compass Therapeutics shares owned by Cape Investment Advisory

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by Cape Investment Advisory from 13F filings

Historical chart of Cape Investment Advisory investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by Cape Investment Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by Cape Investment Advisory

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.6k 1.3k 3.50

More positions owned by Cape Investment Advisory

Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Booking Holdings (BKNG)
Charles Schwab Corporation (SCHW)
Ishares Tr Core S&p500 Etf (IVV)
Iqvia Holdings (IQV)
Spdr Series Trust Portfolio S&p500 (SPLG)
Walt Disney Company (DIS)
Mastercard Incorporated Cl A (MA)
Visa Com Cl A (V)
Applied Materials (AMAT)
Anthem (ELV)

View all positions for Cape Investment Advisory

Top funds holding Compass Therapeutics

Tang Capital Management
OrbiMed Advisors
Suvretta Capital Management
Blackstone Group
Vivo Capital
Enavate Sciences GP
BlackRock
Vanguard Group
Adage Capital Partners GP
MPM Oncology Impact Management
BVF
Rock Springs Capital Management
FMR
Millennium Management
State Street Corporation

View all funds holding Compass Therapeutics